Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2014 1
2015 3
2016 3
2017 2
2018 4
2019 6
2020 7
2021 8
2022 7
2023 10
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Hambly N, Farooqi MM, Dvorkin-Gheva A, Donohoe K, Garlick K, Scallan C, Chong SG, MacIsaac S, Assayag D, Johannson KA, Fell CD, Marcoux V, Manganas H, Morisset J, Comes A, Fisher JH, Shapera S, Gershon AS, To T, Wong AW, Sadatsafavi M, Wilcox PG, Halayko AJ, Khalil N, Cox G, Richeldi L, Ryerson CJ, Kolb M. Hambly N, et al. Among authors: shapera s. Eur Respir J. 2022 Oct 6;60(4):2102571. doi: 10.1183/13993003.02571-2021. Print 2022 Oct. Eur Respir J. 2022. PMID: 35273032 Free article.
Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
Marinescu DC, Hague CJ, Muller NL, Murphy D, Churg A, Wright JL, Al-Arnawoot A, Bilawich AM, Bourgouin P, Cox G, Durand C, Elliot T, Ellis J, Fisher JH, Fladeland D, Grant-Orser A, Goobie GC, Guenther Z, Haider E, Hambly N, Huynh J, Johannson KA, Karjala G, Khalil N, Kolb M, Leipsic J, Lok S, MacIsaac S, McInnis M, Manganas H, Marcoux V, Mayo J, Morisset J, Scallan C, Sedlic T, Shapera S, Sun K, Tan V, Wong AW, Zheng B, Ryerson CJ. Marinescu DC, et al. Among authors: shapera s. Chest. 2023 Dec;164(6):1466-1475. doi: 10.1016/j.chest.2023.07.068. Epub 2023 Aug 2. Chest. 2023. PMID: 37541339
Acute exacerbations of progressive-fibrosing interstitial lung diseases.
Kolb M, Bondue B, Pesci A, Miyazaki Y, Song JW, Bhatt NY, Huggins JT, Oldham JM, Padilla ML, Roman J, Shapera S. Kolb M, et al. Among authors: shapera s. Eur Respir Rev. 2018 Dec 21;27(150):180071. doi: 10.1183/16000617.0071-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578331 Free PMC article. Review.
Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response.
Zheng B, Marinescu DC, Hague CJ, Muller NL, Murphy D, Churg A, Wright JL, Al-Arnawoot A, Bilawich AM, Bourgouin P, Cox G, Durand C, Elliot T, Ellis J, Fisher JH, Fladeland D, Grant-Orser A, Goobie GC, Guenther Z, Haider E, Hambly N, Huynh J, Johannson KA, Karjala G, Khalil N, Kolb M, Leipsic J, Lok S, MacIsaac S, McInnis M, Manganas H, Marcoux V, Mayo J, Morisset J, Scallan C, Sedlic T, Shapera S, Sun K, Tan V, Wong AW, Ryerson CJ. Zheng B, et al. Among authors: shapera s. Rheumatology (Oxford). 2024 Feb 9:keae076. doi: 10.1093/rheumatology/keae076. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38336872
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort.
Marcoux V, Lok S, Mondal P, Assayag D, Fisher JH, Shapera S, Morisset J, Manganas H, Fell CD, Hambly N, Cox PG, Kolb M, Gershon AS, To T, Sadatsafavi M, Khalil N, Wong AW, Wilcox PG, Ryerson CJ, Johannson KA. Marcoux V, et al. Among authors: shapera s. J Thorac Dis. 2023 May 30;15(5):2517-2527. doi: 10.21037/jtd-22-1820. Epub 2023 May 12. J Thorac Dis. 2023. PMID: 37324076 Free PMC article.
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study.
Khor YH, Schulte M, Johannson KA, Marcoux V, Fisher JH, Assayag D, Manganas H, Khalil N, Kolb M, Ryerson CJ; Austin ILD Registry and CARE-PF Investigators; ALLIANCE Study Group; Cox G, Fell CD, Gershon AS, Goh N, Halayko AJ, Lok S, Morisset J, Sadatsafavi M, Shapera S, To T, Wilcox PG, Wong AW. Khor YH, et al. Among authors: shapera s. Eur Respir J. 2023 May 5;61(5):2202163. doi: 10.1183/13993003.02163-2022. Print 2023 May. Eur Respir J. 2023. PMID: 36858445
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease.
Saleem F, Ryerson CJ, Sarma N, Johannson K, Marcoux V, Fisher J, Assayag D, Manganas H, Khalil N, Morisset J, Glaspole IN, Goh N, Oldham JM, Cox G, Fell C, Gershon AS, Halayko A, Hambly N, Lok SD, Shapera S, To T, Wilcox PG, Wong AW, Kolb M, Khor YH. Saleem F, et al. Among authors: shapera s. Ann Am Thorac Soc. 2023 Dec;20(12):1726-1734. doi: 10.1513/AnnalsATS.202303-208OC. Ann Am Thorac Soc. 2023. PMID: 37676933
Characteristics and risk factors of interstitial pneumonia with autoimmune features.
Vahidy S, Agyeman J, Zheng B, Donohoe K, Hambly N, Johannson KA, Assayag D, Fisher JH, Manganas H, Marcoux V, Khalil N, Kolb M, Ryerson CJ; CARE-PF Investigators; Wong AW, Lok S, Morisset J, Fell CD, Shapera S, Gershon AS, Cox G, Halayko AJ, Sadatsafavi M, Wilcox PG, To T. Vahidy S, et al. Among authors: shapera s. Respir Med. 2024 Jan;221:107500. doi: 10.1016/j.rmed.2023.107500. Epub 2023 Dec 22. Respir Med. 2024. PMID: 38142756
Diagnostic criteria for idiopathic pulmonary fibrosis.
Fidler L, Shapera S. Fidler L, et al. Among authors: shapera s. Lancet Respir Med. 2018 Feb;6(2):e6. doi: 10.1016/S2213-2600(18)30020-1. Lancet Respir Med. 2018. PMID: 29413089 No abstract available.
52 results